Australia’s drug dependence: A multi-level response to supply-chain insecurity

Supply problems at the start of the COVID-19 pandemic sparked concerns about fragile pharmaceutical supply chains. Australia must consider how it can drive forward its domestic industry while also being a strong voice for regional cooperation.